CHARACTERIZATION OF A NOVEL G PROTEIN IN HUMAN PLATELETS
人类血小板中新型 G 蛋白的表征
基本信息
- 批准号:3364139
- 负责人:
- 金额:$ 24.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-07-01 至 1995-06-30
- 项目状态:已结题
- 来源:
- 关键词:G protein antibody calcium channel cell membrane electrofocusing electron microscopy genetic library human subject human tissue immunofluorescence technique immunoprecipitation insect poison laboratory rabbit megakaryocytes molecular cloning monomer pertussis toxin phorbols phospholipase A2 phospholipase C phosphorylation platelet activation platelets polymerase chain reaction posttranslational modifications protein kinase C protein structure function receptor second messengers stoichiometry terpene saponin thrombin tissue /cell culture western blottings
项目摘要
This proposal will examine the structure and function of a 40 kDa protein
in platelets which we believe to be the alpha subunit of a guanine
nucleotide-binding regulatory protein or G protein. Based upon our recent
studies, this protein has several novel properties. First, it is
phosphorylated during platelet activation, apparently by protein kinase C.
Second, it is immunologically cross-reactive with G(z-alpha), a putative
alpha subunit that has been cloned from two non-platelet cDNA libraries,
but not yet isolated. Third, in contrast to the other G proteins which have
been a focus for platelet research, it is neither ADP-ribosylated by
pertussis toxin nor recognized by antisera that are specific for known
pertussis toxin-sensitive G proteins, such as G(i-alpha). Even though G(z-
alpha) is not known to be a substrate for protein kinase C, we have
provisionally named the platelet protein "G(z-alpha)(plt)" in
acknowledgement of the immunologic cross-reactivity of the two proteins.
The goal of our studies will be to understand the structure and biology of
G(z-alpha)(plt). Specifically, we will: (1) determine the identity of G(z-
alpha)(plt) and define its relationship to G(z-alpha), (2) identify the
sites at which G(z-alpha)(plt) is phosphorylated, (3) determine the
biochemical consequences of phosphorylation and (4) define the role of G(z-
alpha)(plt) in platelet function.
该提案将检查 40 kDa 蛋白质的结构和功能
在血小板中,我们认为它是鸟嘌呤的α亚基
核苷酸结合调节蛋白或G蛋白。根据我们最近的
研究表明,这种蛋白质具有多种新特性。首先,它是
在血小板活化过程中磷酸化,显然是由蛋白激酶 C 磷酸化。
其次,它与 G(z-alpha) 发生免疫交叉反应,G(z-alpha) 是一种假定的
已从两个非血小板 cDNA 文库克隆的 α 亚基,
但尚未隔离。第三,与其他 G 蛋白相比,
一直是血小板研究的焦点,它既不是 ADP 核糖基化的
百日咳毒素也不被已知特异性的抗血清识别
百日咳毒素敏感 G 蛋白,例如 G(i-alpha)。即使 G(z-
α) 不知道是蛋白激酶 C 的底物,我们有
血小板蛋白暂时命名为“G(z-alpha)(plt)”
承认两种蛋白质的免疫交叉反应性。
我们研究的目标是了解结构和生物学
G(z-α)(plt)。具体来说,我们将: (1) 确定 G(z-
alpha)(plt) 并定义其与 G(z-alpha) 的关系,(2) 识别
G(z-alpha)(plt) 被磷酸化的位点,(3) 确定
磷酸化的生化后果和(4)定义了 G(z-
血小板功能中的α)(plt)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE F BRASS其他文献
LAWRENCE F BRASS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE F BRASS', 18)}}的其他基金
Studies of Physiologic and Pathologic Platelet Plug Formation
生理和病理血小板栓子形成的研究
- 批准号:
10161819 - 财政年份:2020
- 资助金额:
$ 24.4万 - 项目类别:
Studies of Physiologic and Pathologic Platelet Plug Formation
生理和病理血小板栓子形成的研究
- 批准号:
10656284 - 财政年份:2020
- 资助金额:
$ 24.4万 - 项目类别:
Studies of Physiologic and Pathologic Platelet Plug Formation
生理和病理血小板栓子形成的研究
- 批准号:
10434806 - 财政年份:2020
- 资助金额:
$ 24.4万 - 项目类别:
Regulation of the early events of platelet activation
血小板活化早期事件的调节
- 批准号:
8456213 - 财政年份:2010
- 资助金额:
$ 24.4万 - 项目类别:
Regulation of the early events of platelet activation
血小板活化早期事件的调节
- 批准号:
8242745 - 财政年份:2010
- 资助金额:
$ 24.4万 - 项目类别:
Regulation of the early events of platelet activation
血小板活化早期事件的调节
- 批准号:
8065935 - 财政年份:2010
- 资助金额:
$ 24.4万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 24.4万 - 项目类别:
Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 24.4万 - 项目类别:
Grant-in-Aid for Scientific Research (B)